This 1998 clinical trial evaluated the impact of oral glutamine supplementation (30 g/day for 28 days) on immune and gut barrier function in 13 patients with advanced esophageal cancer undergoing radiochemotherapy (5-fluorouracil and cisplatin with mediastinal irradiation). Compared to controls, the glutamine group maintained higher lymphocyte counts (1007 ± 151/mm³
